Maternal morbidity after implementation of a postpartum hemorrhage protocol including use of misoprostol
| Autor: | Luis M. Esteban, Belén Rodríguez-Solanilla, Ricardo Savirón-Cornudella, Bremen De Mucio, Sergio Castán-Mateo, Gerardo Sanz, Ramiro Laborda-Gotor |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
medicine.medical_specialty medicine.medical_treatment Postpartum Hysterectomy Hysterectomy Young Adult 03 medical and health sciences 0302 clinical medicine Pregnancy Oxytocics medicine Humans 030212 general & internal medicine Misoprostol Retrospective Studies Bakri balloon Gynecology 030219 obstetrics & reproductive medicine Cesarean Section business.industry Vaginal delivery Obstetrics Uterine Inertia Postpartum Hemorrhage Obstetrics and Gynecology Anemia General Medicine Delivery Obstetric medicine.disease Uterine atony Female business medicine.drug |
| Zdroj: | International Journal of Gynecology & Obstetrics. 140:198-204 |
| ISSN: | 0020-7292 |
| Popis: | Objective To compare maternal morbidity before and after implementation of a postpartum hemorrhage (PPH) protocol that included misoprostol. Methods A retrospective analysis was performed using data from 34 631 deliveries recorded at a Spanish hospital between January 1, 2007, and December 31, 2014. The PPH protocol was implemented in 2009 and included use of misoprostol and the Bakri balloon. Results The pre-implementation and post-implementation groups comprised 9394 and 25 237 women, respectively. Women in the pre-implementation group tended to have lower hemoglobin levels than did those in the post-implementation group: 811 (8.6%) versus 1349 (5.3%) for levels less than 90 g/L, and 272 (2.9%) versus 497 (2.0%) for levels less than 80 g/L (both P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text